Tagworks Pharmaceuticals

We are excited to announce the initiation of our Phase 0/1 clinical trial, sponsored by @radboudumc , evaluating TGW211 in patients with #HER2positive #tumors. Learn more: bit.ly/4hcgGk8

On #WorldCancerResearchDay, we’re reminded that bold scientific innovation is essential. Hear from Marc Robillard, PhD, Tagworks’ co-founder and CSO, about how we’re advancing pioneering in vivo click chemistry into a new standard of care for patients with #solidtumors.

We’re excited to announce that the third dose level has been initiated in our ongoing Phase 1 clinical trial evaluating our lead #ADC program TGW101 in patients with advanced #solidtumors. Learn more: bit.ly/4859Eej

We’re innovating for patients with #solidtumors so they can have safer, more effective therapies. Developed with our pioneering Click-to-Release approach, our lead #oncology #ADC program called TGW101 is now recruiting for a #clinicaltrial. Learn more: bit.ly/44ykreP

We’re proud to be featured in a #NatureBiotechnology profile on #radiopharmaceuticals! Our Click-to-Release treatment platform shows potential to remove dose-limiting toxicities to more safely and effectively treat #solidtumors. Read here: bit.ly/4mFOoB1

At #AACR2025, we presented preclinical data on the potential of our Click-to-Release treatment platform to enable safe, tolerable, and potent delivery of therapeutic candidates for #solidtumors. View the posters: bit.ly/4cM7yjT #ADCs #oncology

We’re excited to welcome Keith Orford, MD, PhD, as our new CMO! His leadership in #oncology research and clinical drug development will be invaluable as we transition to the clinic. Learn more: bit.ly/4jlSuw3

We’re thrilled to announce the initiation of our Phase 1 clinical trial evaluating TGW101, an #ADC developed with our Click-to-Release treatment platform, in patients with advanced #solidtumors. Learn more: bit.ly/4jrAErw

We look forward to attending #AACR2025! We will share preclinical data that demonstrate the potential of our pioneering Click-to-Release platform to improve the standard of care for patients with #solidtumor #cancers. Learn more: bit.ly/41HXGDZ #ADCs #oncology

We're excited to announce Ken Mills has been appointed our new CEO and that Marc Robillard will continue as CSO & Board member. We look forward to working to bring our Click-to-Release platform and lead ADC program for solid tumors into the clinic in 2025. prnewswire.com/news-releases/…

Proud to have won the second place for this years LSX Lifestars Awards - Series A of the Year. Great recognition for @Tagworkspharma and our fantastic group of investors ! Congrats to Complement Tx and Adcendo and thanks to @lifestarsawards for this great night out !

A concise synthetic approach to highly reactive click-to-release trans-cyclooctene linkers (Robillard et al. @Tagworkspharma) …mistry-europe.onlinelibrary.wiley.com/doi/10.1002/ch…

‘Clicked’ drugs: researchers prove the remarkable chemistry in humans Featuring @Tagworkspharma #portfolio nature.com/articles/s4158…

@NEA Thank you @NEA, Michele Park and James Buxton, for supporting the mission of @Tagworkspharma to deliver click-cleavable ADCs and other therapies to the clinic !

👏🏽 Congratulations, @Tagworkspharma--$65M Series A raised for click-to-release therapeutics! prnewswire.com/news-releases/…

@RoeyJAmir thank you Roey !

Congratulations Marc and @Tagworkspharma team!!!!

@GildeHealthcare thank you @Gildehealthcare for co-leading this great round for #Tagworkspharma !

@YsiosCapital @EIF_EU @icfcat Thank you Thomas and the whole Ysios team for leading this fantastic round !

#Investment I We're thrilled to announce that we have led the $65M Series A #financing of @Tagworkspharma 🎯 #ClicktoRelease approach poised to change the standard of care for patients with solid #tumors. 👉 bit.ly/43T93Yq #oncology #innovation #vc #biotech

@Click_Chemist thank you Dennis !

@Tagworkspharma Congrats Marc and the Tagworks team!

We’re excited to announce that we’ve raised $65 Million in Series A financing to advance a pipeline of Click-to-Release Therapeutics ! tagworkspharma.com/tagworks-pharm…

@PhosphorusFive thank you Christian !!

@Tagworkspharma Congratulations, Marc and team! It is so refreshing to see that investors believe in this beautiful concept. All fingers crossed for bringing it through the clinic. 🤞

Het Nederlandse @Tagworkspharma heeft een grote investeringsronde met succes afgesloten. De financiële impuls biedt het bedrijf de middelen om klinische studies met de belangrijkste kandidaat-ADC in gang te zetten: sciencelink.net/nieuws/tagwork…